Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

References for PMC Articles for PubMed (Select 21459804)

1.

In silico estimates of tissue components in surgical samples based on expression profiling data.

Wang Y, Xia XQ, Jia Z, Sawyers A, Yao H, Wang-Rodriquez J, Mercola D, McClelland M.

Cancer Res. 2010 Aug 15;70(16):6448-55. doi: 10.1158/0008-5472.CAN-10-0021. Epub 2010 Jul 27.

2.

The FOXF2 pathway in the human prostate stroma.

van der Heul-Nieuwenhuijsen L, Dits N, Van Ijcken W, de Lange D, Jenster G.

Prostate. 2009 Oct 1;69(14):1538-47. doi: 10.1002/pros.20996.

PMID:
19562724
3.

Global gene expression analysis of reactive stroma in prostate cancer.

Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, Ittmann M.

Clin Cancer Res. 2009 Jun 15;15(12):3979-89. doi: 10.1158/1078-0432.CCR-08-1899. Epub 2009 Jun 9.

4.

Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.

Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.

Clin Cancer Res. 2009 May 15;15(10):3557-67. doi: 10.1158/1078-0432.CCR-08-1656. Epub 2009 May 15.

5.

Optimizing molecular signatures for predicting prostate cancer recurrence.

Sun Y, Goodison S.

Prostate. 2009 Jul 1;69(10):1119-27. doi: 10.1002/pros.20961.

6.

Screening for prostate cancer: an update.

Shariat SF, Scardino PT, Lilja H.

Can J Urol. 2008 Dec;15(6):4363-74. Review.

7.
8.

Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy.

Leite KR, Camara-Lopes LH, Cury J, Dall'oglio MF, Sañudo A, Srougi M.

Clinics (Sao Paulo). 2008 Jun;63(3):339-42.

9.

Subsequent prostate cancer detection in patients with prostatic intraepithelial neoplasia or atypical small acinar proliferation.

Amin MM, Jeyaganth S, Fahmy N, Bégin L, Aronson S, Jacobson S, Tanguay S, Aprikian AG.

Can Urol Assoc J. 2007 Sep;1(3):245-9.

10.

The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

Simoneau AR, Gerner EW, Nagle R, Ziogas A, Fujikawa-Brooks S, Yerushalmi H, Ahlering TE, Lieberman R, McLaren CE, Anton-Culver H, Meyskens FL Jr.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):292-9. doi: 10.1158/1055-9965.EPI-07-0658.

11.

Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach.

Andriole GL, Bullock TL, Belani JS, Traxel E, Yan Y, Bostwick DG, Humphrey PA.

Urology. 2007 Dec;70(6 Suppl):22-6. doi: 10.1016/j.urology.2007.06.1128.

PMID:
18194707
12.
13.

Global expression analysis of prostate cancer-associated stroma and epithelia.

Richardson AM, Woodson K, Wang Y, Rodriguez-Canales J, Erickson HS, Tangrea MA, Novakovic K, Gonzalez S, Velasco A, Kawasaki ES, Emmert-Buck MR, Chuaqui RF, Player A.

Diagn Mol Pathol. 2007 Dec;16(4):189-97.

PMID:
18043281
14.

Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.

Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM, Ayala GE.

Hum Pathol. 2007 Nov;38(11):1611-20. Epub 2007 Sep 14.

PMID:
17868773
15.
16.

Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells.

Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW, Jaye DL, Moreno CS.

Cancer Res. 2006 Apr 15;66(8):4011-9.

17.

Regularized linear discriminant analysis and its application in microarrays.

Guo Y, Hastie T, Tibshirani R.

Biostatistics. 2007 Jan;8(1):86-100. Epub 2006 Apr 7.

18.

Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis.

Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR.

Cancer Res. 2005 Oct 1;65(19):8887-95.

19.

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.

Stephenson AJ, Smith A, Kattan MW, Satagopan J, Reuter VE, Scardino PT, Gerald WL.

Cancer. 2005 Jul 15;104(2):290-8.

20.

Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood.

Yang SZ, Dong JH, Li K, Zhang Y, Zhu J.

Hepatobiliary Pancreat Dis Int. 2005 May;4(2):227-33.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk